Cited by 214Endometriosis Research and TreatmentUterine Myomas and TreatmentsGynecological conditions and treatments

Adenomyosis: epidemiology, risk factors, clinical phenotype and surgical and interventional alternatives to hysterectomy

Open access
Taran, F., Stewart, E., Brucker, S.·2013·Geburtshilfe und Frauenheilkunde

Abstract

Adenomyosis is an important clinical challenge in gynecology and healthcare economics; in its fully developed form, hysterectomy is often used to treat it in premenopausal and perimenopausal women. Symptoms of adenomyosis typically include menorrhagia, pelvic pain and dysmenorrhea. Moreover, adenomyosis and leiomyomas commonly coexist in the same uterus, and differentiating the symptoms for each pathological process can be problematic. Although it has been recognized for over a century, reliable epidemiological studies on this condition are limited, because only postoperative diagnoses were possible in the past. Minimally invasive surgical techniques (endometrial ablation/resection, myometrial excision/reduction, myometrial electrocoagulation, uterine artery ligation) have had limited success in the treatment of adenomyosis, and the reported data for these procedures have been obtained from case reports or small case series with only short follow-up times. However, newer techniques including uterine artery embolization (UAE) and magnetic resonance imaging guided focused ultrasound (MRgFUS) show promise in treating adenomyosis. The data is strongest for UAE; these studies have the largest patient cohorts. However, none of the UAE studies were randomized or controlled. Thus, despite the clinical importance of adenomyosis, there is little evidence on which to base treatment decisions. The objective of this review is to summarize the epidemiology, risk factors, clinical phenotype and to evaluate the accrued experience with surgical and interventional alternatives to hysterectomy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1055/s-0033-1350840

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In Table 1 of the publication, women's age and symptoms have been reported (chronic pelvic pain, dysmenorrhea, metrorrhagia, dyspareunia, and subfertility).

    “In Table 1 of the publication, women's age and symptoms have been reported (chronic pelvic pain, dysmenorrhea, metrorrhagia, dyspareunia, and subfertility) [26].”

    From Using artificial intelligence to semi-automate trustworthiness assessment of randomized controlled trials: a case study (2025) · cites this paper as [26]

    Table 1 (page not specified in our copy) reports studies of uterine artery embolization, listing patient counts, numbers with improved symptoms, and follow-up. It does not report women’s ages or the listed symptoms. The paper discusses age and some symptoms elsewhere, but not in Table 1. (LLM, conf=0.90)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • Prognostic factors of adenomyosis include age, multiparity, history of uterine surgery, smoking, ectopic pregnancy, and clinical phenotype symptoms.

    “Prognostic factors of adenomyosis include age, multiparity, history of uterine surgery, smoking, ectopic pregnancy, and clinical phenotype symptoms.”

    From Using artificial intelligence to semi-automate trustworthiness assessment of randomized controlled trials: a case study (2025) · cites this paper as [26]

    The Age and Multiparity sections describe the age distribution and high proportion of multiparous women among those with adenomyosis, while the clinical-phenotype discussion describes presenting symptoms. But the Prior uterine surgery section calls that risk factor uncertain, the Smoking section calls the association controversial, and the Ectopic pregnancy section says that proposed association requires more evidence. The paper discusses risk factors and symptoms, not established prognostic factors as the claim implies; no page numbers were available in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Parity is consistently a risk factor for adenomyosis, while smoking is inconsistently protective.

    “Parity is consistently shown to be a risk factor, while smoking is inconsistently shown to be a protective factor [15,18].”

    From The Pathogenesis of Adenomyosis vis-à-vis Endometriosis (2020) · cites this paper as [18]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 5

  1. [2]2. Renner SP, Lermann J, Hackl J et al. Chronische Erkrankung. Endome- triose. Geburtsh Frauenheilk 2012; 72: 914-919
  2. [9]9. Azziz R. Adenomyosis: current perspectives. Obstet Gynecol Clin North Am 1989; 16: 221-235
  3. [11]11. Parazzini FVP, Panazza S, Chatenoud L et al. Risk factors for adenomyo- sis. Hum Reprod 1997;12: 1275-1279
  4. [44]44. Mora S, Diehl T, Stewart EA et al. Prolactin is an autocrine growth regu- lator for human myometrial and leyomyoma cells. J Soc Gynecol Invest 1995; 2: 396
  5. [57]57. Wallwiener D, Rimbach S, Kaufmann M et al. Hysteroscopic endometrial ablation to avoid hysterectomy in high-risk patients. Geburtsh Frauen- heilk 1994; 54: 498-501

Cited by

Sorted by citations

Authors
Taran, F., Stewart, E., & Brucker, S.
Affiliations
  • University of Tübingen (DE)
  • Mayo Clinic (US)
Corresponding author
Taran, F.
Venue
Geburtshilfe und Frauenheilkunde
Published
2013-10-11
Volume
73
Issue
09
Pages
924-931
ISSN
  • 0016-5751 (ISSN-L)
  • 1438-8804
OpenAlex
W2054264645
Cited by
213
References
99
Citations by year
2026: 12 · 2025: 16 · 2024: 23 · 2023: 23 · 2022: 23 · 2021: 22 · 2020: 19 · 2019: 18 · 2018: 12 · 2017: 16 · 2016: 13 · 2015: 11 · 2014: 4
FWCI
11.27
Type
journal article
Language
de
Open access
Locations
  • Geburtshilfe und Frauenheilkunde (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords
adenomyosis, epidemiology, risk factors, clinical phenotype, uterine artery embolization, MR-guided focused ultrasound, minimally invasive surgery, endometrial ablation, uterine artery ligation, leiomyoma, menorrhagia, dysmenorrhea, pelvic pain, perimenopausal women

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review